MAP1LC3A and non-small cell lung carcinoma: As indicated in the diagram (Fig. 8n), UBE2C transcripts negatively regulated by miR-381and interfered by the m6A demethylase ALKBH5 directly and selectively represses ATG3 and LC3 which further phenotypically arrest NSCLC progression.